Bulletin
Investor Alert

Teva Pharmaceutical Industries Ltd. ADR

NYS: TEVA

GO
/marketstate/country/us

After Hours

/zigman2/quotes/205657894/composite

$

12.96

Change

-0.49 -3.64%

Volume

Volume 1.03m

Feb 19, 2020, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205657894/composite

Today's close

$ 12.32

$ 13.45

Change

+1.13 +9.17%

Day low

Day high

$12.51

$13.48

Open
Open: 12.51

52 week low

52 week high

$6.07

$18.05

Open

Market cap

$13.45B

Average volume

17.73M

P/E ratio

N/A

Rev. per Employee

$441,818

EPS

-0.92

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/teva

MarketWatch News on TEVA

  1. Opioid Settlement Faces Objection From Attorneys General, WSJ Reports

    11:43 a.m. Feb. 14, 2020

    - Josh Nathan-Kazis

  2. Teva stock price target raised to $13 from $9 at SunTrust RH

    8:19 a.m. Feb. 13, 2020

    - Tomi Kilgore

  3. Teva stock price target raised to $10 from $8 at J.P. Morgan

    8:10 a.m. Feb. 13, 2020

    - Tomi Kilgore

  4. Teva Pharmaceutical stock price target raised to $16 from $12 at Oppenheimer

    7:45 a.m. Feb. 13, 2020

    - Tomi Kilgore

  5. Teva Pharmaceutical CEO on Bringing His Company Back From the Brink

    4:50 p.m. Feb. 12, 2020

    - Josh Nathan-Kazis

  6. Teva Stock Jumps After Reporting Earnings. What You Need to Know.

    8:34 a.m. Feb. 12, 2020

    - Josh Nathan-Kazis

  7. Teva's stock falls on earnings; Copaxone sales tumble 26%

    7:35 a.m. Feb. 12, 2020

    - Jaimy Lee

  8. Teva shares up 1.2% premarket

    7:10 a.m. Feb. 12, 2020

    - Ciara Linnane

  9. Teva now sees 2020 adj. EPS $2.30 to $2.55; FactSet consensus $2.49

    7:10 a.m. Feb. 12, 2020

    - Ciara Linnane

  10. Teva now sees 2020 revenue $16.6 bln to $17.0 bln; FactSet consensus $17.4 bln

    7:09 a.m. Feb. 12, 2020

    - Ciara Linnane

  11. Teva Q4 revenue $4.468 bln vs. $4.418 bln; FactSet consensus $4.425 bln

    7:08 a.m. Feb. 12, 2020

    - Ciara Linnane

  12. Teva Q4 adj. EPS 62 cents, matching FactSet consensus

    7:07 a.m. Feb. 12, 2020

    - Ciara Linnane

  13. Teva Q4 EPS 10 cents vs loss $2.85

    7:06 a.m. Feb. 12, 2020

    - Ciara Linnane

  14. Teva Reports Earnings Tomorrow. Here’s What to Expect.

    7:15 a.m. Feb. 11, 2020

    - Josh Nathan-Kazis

  15. Oklahoma sues three opioid distributors over ‘man-made crisis’

    7:48 p.m. Jan. 13, 2020

    - Associated Press

  16. Opioid Stocks Fall on News of Federal Criminal Investigation

    9:37 a.m. Nov. 27, 2019

    - Josh Nathan-Kazis

  17. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/teva

Other News on TEVA

  1. Teva down 5% after hours on failed deutetrabenazine study

    4:15 p.m. Today

    - Seeking Alpha

  2. 3 Reasons Why Teva Pharmaceutical Is Still A Good Buy

    1:36 p.m. Today

    - Seeking Alpha

  3. Teva: The Road To Perdition Has Turned Into A Path Towards Redemption

    8:27 a.m. Today

    - Seeking Alpha

  4. Positive Catalysts Make Amarin Stock a Buy on Current Weakness

    6:40 a.m. Today

    - InvestorPlace.com

  5. Opioids Made TEVA Stock Untouchable But Things Seem to be Changing

    5:01 a.m. Today

    - InvestorPlace.com

  6. Why Teva’s Grand Turnaround Could Just Be Getting Started

    12:50 p.m. Feb. 18, 2020

    - 247WallSt.com

  7. Opioid-related payouts to less than expected - NYT

    7:57 a.m. Feb. 18, 2020

    - Seeking Alpha

  8. Opioid-related payouts to be less than expected - NYT

    7:57 a.m. Feb. 18, 2020

    - Seeking Alpha

  9. States Spurn Drug Industry’s Opioid-Settlement Offer

    6:58 p.m. Feb. 14, 2020

    - Jared S. Hopkins

  10. Leaner, More Agile Teva Has Brighter Days Ahead

    1:42 p.m. Feb. 13, 2020

    - GuruFocus.com

  11. 15 Stocks to Buy Based On The 2020 U.S. Presidential Election

    11:47 a.m. Feb. 13, 2020

    - InvestorPlace.com

  12. 3 Reasons Why Beaten-Up Teva Stock Could Have a Big 2020

    10:56 a.m. Feb. 13, 2020

    - InvestorPlace.com

  13. Loading more headlines...
/news/pressrelease/company/us/teva

Press Releases on TEVA

  1. XLF, ISZE: Big ETF Outflows

    10:48 a.m. Today

    - MarketNewsVideo.com

  2. Nootropics Market To Reach USD 5.32 Billion By 2026 | Reports And Data

    10:00 a.m. Today

    - GlobeNewswire

  3. Olanzapine Market Innovations And Top Companies by 2029 | Lilly and Teva Pharmaceutical

    7:36 a.m. Today

    - marketresearch.biz

  4. Myasthenia Gravis Treatment Market: Global Industry Analysis and Opportunity Assessment 2019-2025

    4:33 a.m. Today

    - Brandessence Market Research

  5. Loading more headlines...

Rates »

Link to MarketWatch's Slice.